Moderna Stock Crashes 25% After Cancer-Vaccine Data Leak

Moderna shares tumbled as reported results for its cancer vaccine with Merck circulated ahead of a planned conference presentation.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。